Probably an amount that would still allow 3 more arm in this trial to be dosed. And without anymore dilution while doing so.
CHM needs to burn money atm to get arms dosed to gain enough data to get one of the BP they have been sharing data with to come on-board as a partner. At $760k per arm it adds up. The sooner they get the data the sooner the binary decision of success or failure can be made. And that is where potential share holder gains will come from. By dragging feet and to continue slowly progressing helps noone.
Ann: Chimeric receives $2.5 M advance on FY25 R&D tax incentive, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $15.69K | 3.919M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 21936206 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 24685267 | 27 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |